Mycronic AB (MYCR) AI Stock Analysis

• Market Cap: kr46.02B
• Dividend Yield: 1.71%
• Average Volume (3M): 171.55K
• Price to Earnings (P/E): 27.9
• Beta (1Y): 0.96
• Revenue Growth: 14.48%
• EPS Growth: 0.52%
• Country: SE
• Employees: 2,318
• Sector: General
• Sector Strength: N/A
• Industry: Industrial - Machinery
• EPS (TTM): 1.42
• Shares Outstanding: 195,833,020
• 10 Day Avg. Volume: 161,326
• 30 Day Avg. Volume: 171,548
• PEG Ratio: -3.77
• Price to Book (P/B): 6.13
• Price to Sales (P/S): 5.49
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 8.65
• Revenue Forecast (FY): kr8.17B

• Rating: 63 Neutral
• Price Target: kr239.00 ▲(10.34% Upside)
• Action: Reiterated Date: 02/07/26
• Date: Action: Reiterated 02/07/26

The score is supported primarily by strong underlying financial quality (high margins, strong ROE, and very low leverage), but is weighed down by the 2025 downturn and cash-flow weakness, along with clearly bearish technical signals. Valuation is moderate, with only a modest dividend offset.

Positive Factors

Balance-sheet strength

Very low leverage and materially growing equity provide durable financial flexibility. Low debt limits solvency risk through cyclical downturns and supports capital allocation for R&D, service expansion, or opportunistic investment without forcing asset sales or equity raises, preserving long-term strategy execution.

Negative Factors

2025 revenue collapse

A near‑50% revenue decline in 2025 signals acute order-cycle exposure and potential demand disruption in key end markets. Such large, rapid volume shocks can impair capacity utilization, delay margins recovery, and require costly working‑capital or restructuring actions that weaken earnings durability for multiple quarters.

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB (publ), together with its subsidiaries, develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally...

Read more

Mycronic AB (publ), together with its subsidiaries, develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally...

How the Company Makes Money

Mycronic primarily makes money by selling complex, high-value capital equipment used in electronics and semiconductor production, complemented by recurring aftermarket revenues. Key revenue streams typically include: (1) New equipment sales: Reven...

Read more

Mycronic primarily makes money by selling complex, high-value capital equipment used in electronics and semiconductor production, complemented by recurring aftermarket revenues. Key revenue streams typically include: (1) New equipment sales: Reven...

Mycronic AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.94B	7.06B	5.71B	5.12B	4.63B
Gross Profit	4.12B	3.72B	2.72B	2.29B	2.28B
EBITDA	2.30B	2.32B	1.39B	1.11B	1.20B
Net Income	1.56B	1.68B	998.00M	741.00M	828.00M
Balance Sheet
Total Assets	10.92B	10.41B	8.34B	7.34B	6.14B
Cash, Cash Equivalents and Short-Term Investments	2.32B	3.01B	2.14B	1.27B	683.00M
Total Debt	348.00M	219.00M	228.00M	270.00M	243.00M
Total Liabilities	3.81B	3.84B	3.06B	2.64B	2.14B
Stockholders Equity	7.11B	6.53B	5.25B	4.66B	3.96B
Cash Flow
Free Cash Flow	0.00	1.64B	1.41B	712.00M	908.00M
Operating Cash Flow	1.41B	1.87B	1.61B	853.00M	998.00M
Investing Cash Flow	-1.13B	-500.00M	-195.00M	67.00M	-1.22B
Financing Cash Flow	-862.00M	-552.00M	-447.00M	-382.00M	-437.00M

Mycronic AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 216.60
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Positive. The current price of 216.6 is above the 20-day moving average (MA) of 214.76, above the 50-day MA of 206.12, and above the 200-day MA of 210.57, indicating a bullish trend. The MACD of 4.37 indicates Negative momentum. The RSI at 60.69 is Neutral, neither overbought nor oversold. The STOCH value of 77.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ATCO.B	77 Outperform	kr832.74B	27.39	26.43%	2.03%	-2.38%	-4.00%
ATCO.A	76 Outperform	kr832.74B	30.60	24.69%	1.82%	-2.38%	-4.00%
ALFA	73 Outperform	kr225.01B	23.27	20.42%	1.84%	3.54%	20.94%
SAND	70 Outperform	kr493.35B	25.67	16.39%	1.94%	-1.77%	21.13%
MYCR	63 Neutral	kr46.02B	27.94	22.44%	1.71%	14.48%	0.52%
TREL.B	61 Neutral	kr83.64B	24.91	9.65%	1.95%	2.73%	7.56%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

Mycronic AB Corporate Events